Determine the necessary mass, volume, or concentration for preparing a solution.
This is a demo store. No orders will be fulfilled.
| SKU | Size | Availability |
Price | Qty |
|---|---|---|---|---|
|
T413228-1g
|
1g |
3
|
$957.90
|
|
|
T413228-5g
|
5g |
3
|
$3,434.90
|
|
Beta Amyloid Inhibitors
| Synonyms | Tabersonine monohydrochloride | E74579 | HY-N1431A | UNII-DGR7D6J5TR | Aspidospermidine-3-carboxylic acid, 2,3,6,7-tetradehydro-, methyl ester, monohydrochloride, (5.alpha.,12.beta.,19.alpha.)- | TabersonineHydrochloride | Aspidospermidine-3-carboxylic ac |
|---|---|
| Specifications & Purity | ≥98% |
| Biochemical and Physiological Mechanisms | Tabersonine, an ingredient extracted from the bean of Voacanga africana, is a potent inhibitor against Aβ(1−42) aggregation and toxicity. |
| Storage Temp | Store at -20°C |
| Shipped In |
Ice chest + Ice pads This product requires cold chain shipping. Ground and other economy services are not available. |
| Product Description |
Information Tabersonine hydrochloride Tabersonine, an ingredient extracted from the bean of Voacanga africana, is a potent inhibitor against Aβ(1−42) aggregation and toxicity. Targets Aβ(1−42) aggregation In vitro Tabersonine disrupts Aβ(1−42) aggregation and ameliorates Aβ aggregate-induced cytotoxicity. It binds to Aβ(1−42) oligomers more strongly than to Aβ(1−42) monomers with Kd values of 69 μM and 535 μM, respectively. In vivo The biocompatibility and small size essential for permeating the blood−brain barrier make tabersonine a potential therapeutic drug candidate for treating Alzheimer\'s disease (AD). Product Application: (-)-Tabersonine Hydrochloride is the hydrochloride salt of (-)-Tabersonine. (-)-Tabersonine is one of the terpenoid indole alkaloids (TIAs) from Catharanthus roseus. (-)-Tabersonine shows hypotensive activity, anti-tumor activity, hypoglycemic, diuretic activity. Cell Research(from reference) Cell lines:SH-SY5Y cell Concentrations:10 μM Incubation Time:24 h |
Taxonomy Tree
| Kingdom | Organic compounds |
|---|---|
| Superclass | Alkaloids and derivatives |
| Class | Plumeran-type alkaloids |
| Subclass | Not available |
| Intermediate Tree Nodes | Not available |
| Direct Parent | Plumeran-type alkaloids |
| Alternative Parents | Carbazoles Indolines Aralkylamines Secondary alkylarylamines Benzenoids N-alkylpyrrolidines Methyl esters Enoate esters Vinylogous amides Trialkylamines Amino acids and derivatives Enamines Azacyclic compounds Monocarboxylic acids and derivatives Organic oxides Hydrochlorides Hydrocarbon derivatives Carbonyl compounds |
| Molecular Framework | Aromatic heteropolycyclic compounds |
| Substituents | Plumeran-type alkaloid - Carbazole - Indole or derivatives - Dihydroindole - Secondary aliphatic/aromatic amine - Aralkylamine - N-alkylpyrrolidine - Benzenoid - Pyrrolidine - Methyl ester - Enoate ester - Alpha,beta-unsaturated carboxylic ester - Vinylogous amide - Amino acid or derivatives - Tertiary aliphatic amine - Tertiary amine - Carboxylic acid ester - Organoheterocyclic compound - Carboxylic acid derivative - Secondary amine - Enamine - Monocarboxylic acid or derivatives - Azacycle - Organic oxide - Organic oxygen compound - Organic nitrogen compound - Hydrochloride - Organonitrogen compound - Organooxygen compound - Hydrocarbon derivative - Amine - Carbonyl group - Aromatic heteropolycyclic compound |
| Description | This compound belongs to the class of organic compounds known as plumeran-type alkaloids. These are alkaloids with a structure based on the plumeran skeleton. Plumeran is a pentacyclic compound that consists of a pyrrolidine ring shed to the quinoline moiety of pyrido[3,2-c]carbazole ring system. |
| External Descriptors | Not available |
|
|
|
| Pubchem Sid | 504767112 |
|---|---|
| Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/504767112 |
| IUPAC Name | methyl (1R,12R,19S)-12-ethyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,9,13-pentaene-10-carboxylate;hydrochloride |
| INCHI | InChI=1S/C21H24N2O2.ClH/c1-3-20-9-6-11-23-12-10-21(19(20)23)15-7-4-5-8-16(15)22-17(21)14(13-20)18(24)25-2;/h4-9,19,22H,3,10-13H2,1-2H3;1H/t19-,20-,21-;/m0./s1 |
| InChIKey | BBASQSWPQOKOQI-OCIDDWSYSA-N |
| Smiles | CCC12CC(=C3C4(C1N(CC4)CC=C2)C5=CC=CC=C5N3)C(=O)OC.Cl |
| Isomeric SMILES | CC[C@]12CC(=C3[C@@]4([C@H]1N(CC4)CC=C2)C5=CC=CC=C5N3)C(=O)OC.Cl |
| PubChem CID | 12443187 |
| Molecular Weight | 372.89 |
| Solubility | Solubility (25°C) In vitro DMSO: 75 mg/mL (201.13 mM); Ethanol: 75 mg/mL (201.13 mM); Water: Insoluble; |
|---|---|
| DMSO(mg / mL) Max Solubility | 40 |
| DMSO(mM) Max Solubility | 107.2702406 |
| Molecular Weight | 372.900 g/mol |
| XLogP3 | |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 3 |
| Exact Mass | 372.16 Da |
| Monoisotopic Mass | 372.16 Da |
| Topological Polar Surface Area | 41.600 Ų |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 669.000 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| The total count of all stereochemical bonds | 0 |
| Covalently-Bonded Unit Count | 2 |